FDA Approves Faricimab Vabysmo A Bispecific Antibody To Treat Retinal Disease
The recent development of bispecific antibodies represents breakthrough therapy in the management of wide range of chronic multifactorial diseases.
Source: biospace.com
Stay updated with breaking news from Updated Every Quarter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The recent development of bispecific antibodies represents breakthrough therapy in the management of wide range of chronic multifactorial diseases.